|
Treatment-resistant schizophrenia
|
66 (75.0)
|
|
Treatment-resistant schizoaffective disorder
|
5 (5.7)
|
|
Treatment resistant bipolar disorder
|
5 (5.7)
|
|
Schizophrenia with suicidality
|
6 (6.8)
|
|
Tardive dyskinesia
|
3 (3.4)
|
|
Parkinsonism with psychotic features
|
1 (1.1)
|
|
Neuroacanthocytosis
|
1 (1.1)
|
|
Psychotic depression
|
1 (1.1)
|
|
Comorbidity
|
|
None
|
81 (92.0)
|
|
Hypothyroidism
|
4 (4.5)
|
|
Hypertension
|
1 (1.1)
|
|
Diabetes mellitus
|
1 (1.1)
|
|
Parkinsonism
|
1(1.1)
|
|
No. of antipsychotics used prior to clozapine
|
|
2 (two)
|
38 (43.2)
|
|
> 2 (more than two)
|
50 (56.8)
|
|
Antipsychotic used prior to clozapine
|
|
Haloperidol
|
66 (75)
|
|
Chlorpromazine
|
2 (2.3)
|
|
Olanzapine
|
65 (73.9)
|
|
Risperidone
|
34 (38.6)
|
|
Amisulpride
|
11 (12.5)
|
|
Quetiapine
|
5 (5.7)
|
|
Aripiprazole
|
4 (4.5)
|
|
Paliperidone
|
1 (1.1)
|
|
Dose range of clozapine (in mgs)
|
|
<= 100 mgs
|
5 (5.7)
|
|
101–200 mgs
|
22 (25.0)
|
|
201–300 mgs
|
21 (23.9)
|
|
301–400 mgs
|
22 (25.0)
|
|
401–500 mgs
|
11 (12.5)
|
|
501–600 mgs
|
3 (3.4)
|
|
> 600 mgs
|
4 (4.5)
|
